1-3 of 3
Ifigenia Saborit
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in vivo by down-regulation of the prosurvival ER chaperone BiP/Grp78

Gaël Roué, Patricia Pérez-Galán, Ana Mozos, Mónica López-Guerra, Sílvia Xargay-Torrent, Laia Rosich, Ifigènia Saborit-Villarroya, Emmanuel Normant, Elias Campo, Dolors Colomer
Journal: Blood
Blood (2011) 117 (4): 1270–1279.
https://doi.org/10.1182/blood-2010-04-278853
Published: 2011
Includes: Supplemental data
Journal Articles

E2A Transcriptionally Regulates CD38 Expression In Chronic Lymphocytic Leukemia

Ifigenia Saborit-Villarroya, Tiziana Vaisitti, Davide Rossi, Giovanni D’Arena, Gianluca Gaidano, Fabio Malavasi, Silvia Deaglio
Journal: Blood
Blood (2010) 116 (21): 3599.
https://doi.org/10.1182/blood.V116.21.3599.3599
Published: 2010
Journal Articles

Human CD38 Is a Potential Therapeutic Target for Sekected Chronic Lymphocytic Leukemia cases.

Silvia Deaglio, Semra Aydin, Tiziana Vaisitti, Luciana Bergui, Giovanni D’Arena, Lisa Bonello, Ifigenia Saborit, Davide Rossi, Gianluca Gaidano, Giovanna Chiorino, Fabio Malavasi
Journal: Blood
Blood (2008) 112 (11): 2096.
https://doi.org/10.1182/blood.V112.11.2096.2096
Published: 2008